Teva Pharmaceutical Industries Limited TEVA

Set alert

Price alert · TEVA

All alert types
42.03 USD +1.33 +3.27%

As of Nov 3, 3:12 PM ET

Bid
42.02 × 1
Ask
42.06 × 1
41.54 Day range 43.34
20.46 52-week range 42.09
YTD
+34.67%
1 year
+104.82%
Open
41.91
Prev close
40.70
Mkt cap
49.09B
Vol
8.54M
Avg vol
5.60M
EPS
0.60
P/E
70.15
Div yield
0.00%
More statistics
Low
41.54
High
43.34
Forward P/E
13.18
Beta
0.84
Short ratio
4.40
Inst. own
30.06%
Dividend
0.00
Ex-div date
Nov 27, 2017
Earnings
Nov 3, 2026
50-d avg
39.09
200-d avg
34.58
1y target
47.58

15m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Events in this range
  • Nov 2, 2026Rating: HC Wainwright & Co. · — → Buy
  • Nov 3, 2026Earnings: —; estimate 0.72; surprise —%
Signals (38)
NameTimeAgo
SMA: BearishNov 3, 2:25 PM47 minutes ago
SMA: BullishNov 3, 1:40 PM1 hour ago
MACD: Sell SignalNov 3, 12:25 PM2 hours ago
SMA: BearishNov 3, 11:25 AM3 hours ago
RSI: OverboughtNov 3, 10:10 AM5 hours ago
SMA: BullishNov 3, 9:40 AM5 hours ago
SMA: BullishNov 3, 9:40 AM5 hours ago
MACD: Buy SignalNov 3, 9:40 AM5 hours ago
MACD: Sell SignalNov 2, 4:00 PM23 hours ago
SMA: BearishNov 2, 3:40 PM23 hours ago
SMA: BearishNov 2, 3:40 PM23 hours ago
SMA: BullishNov 2, 2:55 PM1 day ago
MACD: Buy SignalNov 2, 2:55 PM1 day ago
SMA: BullishNov 2, 2:40 PM1 day ago
RSI: OversoldNov 2, 1:40 PM1 day ago
SMA: BearishNov 2, 12:40 PM1 day ago
SMA: BullishNov 2, 12:25 PM1 day ago
SMA: BearishNov 2, 9:55 AM1 day ago
MACD: Sell SignalNov 2, 9:55 AM1 day ago
SMA: BearishNov 2, 9:40 AM1 day ago

Newest 20 of 38.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 47.58 +13.2% upside
Target (low)
42.00
Target (mean)
47.58
Target (high)
55.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
  • Strong buy4
  • Buy8
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TEVA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.73020.60 – 0.890.000.0%4.24B-5.3%10
Next quarter0.754640.68 – 0.970.000.0%4.22B-10.3%10
Current year2.111.91 – 2.940.000.0%16.65B-3.5%13
Next year3.092.86 – 3.352.11+46.6%17.23B+3.5%13

Upgrades and downgrades

The latest rating changes

TEVA analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026HC Wainwright & Co.Initiated—Buy
Oct 15, 2026BarclaysMaintainedOverweightOverweight
Oct 12, 2026JP MorganMaintainedOverweightOverweight
Oct 1, 2026TD CowenInitiated—Buy
Sep 23, 2026OppenheimerInitiated—Outperform
Sep 9, 2026Leerink PartnersInitiated—Outperform
Sep 4, 2026UBSMaintainedBuyBuy
Aug 12, 2026BarclaysMaintainedOverweightOverweight
Jul 28, 2026Piper SandlerMaintainedOverweightOverweight
May 6, 2026BarclaysMaintainedOverweightOverweight
Apr 30, 2026JP MorganMaintainedOverweightOverweight
Apr 30, 2026UBSMaintainedBuyBuy
Apr 30, 2026Piper SandlerReiteratedOverweightOverweight
Apr 30, 2026Truist SecuritiesMaintainedBuyBuy
Apr 9, 2026B of A SecuritiesMaintainedBuyBuy
Mar 4, 2026Piper SandlerReiteratedOverweightOverweight
Feb 18, 2026Truist SecuritiesMaintainedBuyBuy
Feb 9, 2026Goldman SachsMaintainedBuyBuy
Jan 30, 2026BarclaysMaintainedOverweightOverweight
Jan 29, 2026ScotiabankMaintainedSector OutperformSector Outperform
Jan 29, 2026Truist SecuritiesMaintainedBuyBuy
Jan 6, 2026JefferiesMaintainedBuyBuy
Dec 22, 2025Piper SandlerMaintainedOverweightOverweight
Dec 19, 2025Goldman SachsMaintainedBuyBuy
Dec 16, 2025JP MorganMaintainedOverweightOverweight
Dec 9, 2025B of A SecuritiesMaintainedBuyBuy
Dec 9, 2025BarclaysInitiated—Overweight
Dec 8, 2025Goldman SachsMaintainedBuyBuy
Dec 5, 2025ScotiabankInitiated—Sector Outperform
Nov 6, 2025JP MorganMaintainedOverweightOverweight